Literature DB >> 18434539

DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation.

Kedar Hastak1, Rajib K Paul, Mukesh K Agarwal, Vijay S Thakur, A R M Ruhul Amin, Sudesh Agrawal, R Michael Sramkoski, James W Jacobberger, Mark W Jackson, George R Stark, Munna L Agarwal.   

Abstract

p53-dependent G(1) and G(2) cell cycle checkpoints are activated in response DNA damage that help to maintain genomic stability. p53 also helps to protect cells from damage that occurs during S phase, for example, when the cells are starved for DNA precursors or irradiated with a low dose of UV. p53 is activated in normal cells starved for pyrimidine nucleotides by treatment with N-(phosphonacetyl)-l-aspartate (PALA). The treated cells progress through a first S phase with kinetics similar to those of untreated cells. However, the DNA of the treated cells begins to become damaged rapidly, within 12 h, as revealed by a comet assay, which detects broken DNA, and by staining for phosphorylated histone H2AX, which accumulates at sites of DNA damage. Because the cells survive, the damage must be reversible, suggesting single-strand breaks or gaps as the most likely possibility. The transiently damaged DNA stimulates activation of ATR and CHK1, which in turn catalyze the phosphorylation and accumulation of p53. Although PALA-induced DNA damage occurs only in dividing cells, the p53 that is activated is only competent to transcribe genes such as p21 and macrophage inhibitory cytokine 1 (whose products regulate G(2) and G(1) or S phase checkpoints, respectively) after the cells have exited the S phase during which damage occurs. We propose that p53 is activated by stimulation of mismatch repair in response to the misincorporation of deoxynucleotides into newly synthesized DNA, long before the lack of pyrimidine nucleoside triphosphates causes the rate of DNA synthesis to slow appreciably.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434539      PMCID: PMC2359797          DOI: 10.1073/pnas.0802080105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 2.  A concomitant ATP-depleting strategy markedly enhances anticancer agent activity.

Authors:  D S Martin; D Spriggs; J A Koutcher
Journal:  Apoptosis       Date:  2001 Feb-Apr       Impact factor: 4.677

3.  Protein roadblocks and helix discontinuities are barriers to the initiation of mismatch repair.

Authors:  Anna Pluciennik; Paul Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

4.  ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.

Authors:  Paul Nghiem; Peter K Park; Yong-son Kim Ys; Bimal N Desai; Stuart L Schreiber
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

5.  N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture.

Authors:  E A Swyryd; S S Seaver; G R Stark
Journal:  J Biol Chem       Date:  1974-11-10       Impact factor: 5.157

6.  A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

Authors:  A C Begg; N J McNally; D C Shrieve; H Kärcher
Journal:  Cytometry       Date:  1985-11

7.  A new biomarker for mitotic cells.

Authors:  James W Jacobberger; Phyllis S Frisa; R Michael Sramkoski; Tammy Stefan; Keith E Shults; Deena V Soni
Journal:  Cytometry A       Date:  2008-01       Impact factor: 4.355

Review 8.  Analyzing the G2/M checkpoint.

Authors:  George R Stark; William R Taylor
Journal:  Methods Mol Biol       Date:  2004

9.  Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

Authors:  Michele Albertoni; Phillip H Shaw; Michimasa Nozaki; Sophie Godard; Mirna Tenan; Marie-France Hamou; Douglas W Fairlie; Samuel N Breit; Vishwas M Paralkar; Nicolas de Tribolet; Erwin G Van Meir; Monika E Hegi
Journal:  Oncogene       Date:  2002-06-20       Impact factor: 9.867

10.  p53 accumulates but is functionally impaired when DNA synthesis is blocked.

Authors:  V Gottifredi; S Shieh; Y Taya; C Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  27 in total

1.  Macrophage Phosphoproteome Analysis Reveals MINCLE-dependent and -independent Mycobacterial Cord Factor Signaling.

Authors:  Madlen Hansen; Julian Peltier; Barbara Killy; Bushra Amin; Barbara Bodendorfer; Anetta Härtlova; Sebastian Uebel; Markus Bosmann; Jörg Hofmann; Christian Büttner; Arif B Ekici; Mario Kuttke; Henrik Franzyk; Camilla Foged; Sandra Beer-Hammer; Gernot Schabbauer; Matthias Trost; Roland Lang
Journal:  Mol Cell Proteomics       Date:  2019-01-11       Impact factor: 5.911

2.  p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.

Authors:  Vijay S Thakur; A R M Ruhul Amin; Rajib K Paul; Kalpana Gupta; Kedar Hastak; Mukesh K Agarwal; Mark W Jackson; David N Wald; Hasan Mukhtar; Munna L Agarwal
Journal:  Cancer Lett       Date:  2010-05-04       Impact factor: 8.679

3.  ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway.

Authors:  Amitabha Chakrabarti; Kalpana Gupta; James Prabhakar Sharma; Jinbo Yang; Anju Agarwal; Abigail Glick; Youwei Zhang; Munna Agarwal; Mukesh K Agarwal; David N Wald
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

Review 4.  Deoxyribonucleotides as genetic and metabolic regulators.

Authors:  Christopher K Mathews
Journal:  FASEB J       Date:  2014-06-13       Impact factor: 5.191

5.  Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway.

Authors:  Anastasia A Khutornenko; Vladimir V Roudko; Boris V Chernyak; Andrey B Vartapetian; Peter M Chumakov; Alexandra G Evstafieva
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint.

Authors:  Dinesh Kumar; Jörgen Viberg; Anna Karin Nilsson; Andrei Chabes
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

7.  The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.

Authors:  Ilaria Marzi; Maria Grazia Cipolleschi; Massimo D'Amico; Theodora Stivarou; Elisabetta Rovida; Maria Cristina Vinci; Silvia Pandolfi; Persio Dello Sbarba; Barbara Stecca; Massimo Olivotto
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

8.  Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.

Authors:  Yun Dai; Shuang Chen; Xin-Yan Pei; Jorge A Almenara; Lora B Kramer; Charis A Venditti; Paul Dent; Steven Grant
Journal:  Blood       Date:  2008-07-09       Impact factor: 22.113

Review 9.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

10.  p53 suppresses structural chromosome instability after mitotic arrest in human cells.

Authors:  W B Dalton; B Yu; V W Yang
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.